Abstract
Genetic and epigenetic studies of gene variants reveal a potential genomic target for treating hemoglobin disorders.
Original language | English (US) |
---|---|
Pages (from-to) | 206-207 |
Number of pages | 2 |
Journal | Science |
Volume | 342 |
Issue number | 6155 |
DOIs | |
State | Published - 2013 |
All Science Journal Classification (ASJC) codes
- General